1065745

Pernix Therapeutics Holdings, Inc. — FEI 3011081729

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 13, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morristown, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures